Canary in a Covid Mine: Indonesia’s Harrowing Surge-Upon-a-Surge Poses Test for China’s Coronavac (with Bob Herrera-Lim)

Bob Herrera Lim, Southeast Asia risk analyst for the consultancy Teneo, places Indonesia’s precipitous, unabated case spike in a regional context. With the most vaccinated people per capita in the region (save Singapore), Indonesia poses a test for how well Sinovac’s Coronavac vaccine fares against the now predominant Delta variant. And while a public health crisis in Malaysia precipitated the downfall of a government, the same is hardly likely in Indonesia. Plus: Jeff and K...